Copyright
©The Author(s) 2015.
World J Gastrointest Endosc. Feb 16, 2015; 7(2): 102-109
Published online Feb 16, 2015. doi: 10.4253/wjge.v7.i2.102
Published online Feb 16, 2015. doi: 10.4253/wjge.v7.i2.102
Drugs | Onset of action (min) | Duration of action (min) | Usual doses | FDA pregnancy category | Adverse effects |
Pethidine | 3-6 | 60-180 | 25-100 mg | C | Respiratory depression, vomiting |
Fentanyl | 1-2 | 30-60 | 50-200 μg | C | Respiratory depression, vomiting |
Alfentanyl | < 1 | 30-60 | 0.250-2 mg | C | Respiratory and cardiovascular depression |
Midazolam | 1-2 | 15-80 | 1-6 mg | D | Respiratory depression, disinhibition |
Propofol | < 1 | 4-8 | 40-400 mg | B | Respiratory and cardiovascular depression |
Flumazenil | 1-2 | 60 | 0.1-1 mg | C | Agitation, withdrawal symptoms |
Naloxone | 1-2 | 30-45 | 0.2-1 mg | B | Narcotic withdrawal |
- Citation: Ferreira AO, Cravo M. Sedation in gastrointestinal endoscopy: Where are we at in 2014? World J Gastrointest Endosc 2015; 7(2): 102-109
- URL: https://www.wjgnet.com/1948-5190/full/v7/i2/102.htm
- DOI: https://dx.doi.org/10.4253/wjge.v7.i2.102